Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × eribulin × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Carboplatin 7 Cisplatin 6 pembrolizumab 5 Radiotherapy 5 Paclitaxel 4 Cetuximab 4 Drug Therapy 3 toripalimab 2 osimertinib 2 X-Rays 2 Fulvestrant 2 Fluorouracil 2 Chemoradiotherapy 2 trastuzumab deruxtecan 1 tisotumab vedotin 1 tislelizumab 1 ribociclib 1 pralsetinib 1 pamiparib 1 palbociclib 1 monalizumab 1 fludarabine 1 exemestane 1 entrectinib 1 disitamab vedotin 1 Therapeutics 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡